February 20, 2017 7:13 PM ET

Healthcare Equipment and Supplies

Company Overview of Neuravi Limited

Company Overview

Neuravi Limited designs and develops clot retrieval devices for restoring blood flow in patients who have suffered ischemic strokes due to blockage of an artery to the brain. It offers EmboTrap revascularization devices for the treatment of acute ischemic strokes to patients in Belgium, Denmark, Finland, France, Germany, Ireland, Italy, the Netherlands, Norway, Spain, Sweden, and Switzerland. The company was incorporated in 2009 and is based in Galway, Ireland.

Parkmore Business Park West



Founded in 2009


353 9 139 4114


353 9 139 4025

Key Executives for Neuravi Limited

Chief Executive Officer
Chief Technology Officer
Vice President of U.S. Sales and Marketing
Age: 57
Compensation as of Fiscal Year 2016.

Neuravi Limited Key Developments

Neuravi Reports EUR 15 Million in Venture Debt Financing from IPF Partners

Neuravi reported EUR 15 million in venture debt financing from IPF Partners. This financing allows Neuravi to invest in U.S. commercialization and stroke treatment portfolio expansion, building upon successful commercialization of the company's EmboTrap Revascularization Device in Europe and rapid progress enrolling the ARISE II U.S. pivotal study. The company said that landmark acute stroke clinical trials published in 2014 and 2015 demonstrating the superiority of stent retriever technology in treating large vessel strokes have driven a surge in the number of stent retriever procedures.

Neuravi Limited Presents at 2016 Canaccord Genuity Medical Technology & Diagnostics Forum, Nov-17-2016 04:40 PM

Neuravi Limited Presents at 2016 Canaccord Genuity Medical Technology & Diagnostics Forum, Nov-17-2016 04:40 PM. Venue: Westin Grand Central, 212 East 42nd Street, New York, New York, United States.

Neuravi Announces European Launch of EmboTrap II Stent Retriever for the Treatment of Acute Stroke

Neuravi announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available enhancements to the EmboTrap stent retriever platform, the EmboTrap® II Revascularization Device. Adoption of endovascular stroke therapy procedures for the treatment of acute ischemic stroke continues to grow significantly following compelling data from multiple large-scale randomized trials last year. These trials confirmed the value of using stent retriever thrombectomy to rapidly clear occlusive clots from large cerebral vessels. The novel EmboTrap was fully commercialized in Europe last year, and with the introduction of the EmboTrap II, Neuravi is bringing further innovation to the market. The new device leverages the EmboTrap platform design, engineered to trap and remove a variety of clot types and rapidly re-establish flow, with an integrated fragment protection zone. The EmboTrapII device is designed to address a broader range of clot lengths, with sizes that are deliverable through an 0.021” microcatheter. Neuravi will be introducing the system at the 8th annual Congress of the European Society of Minimally Invasive Neurological Therapy in Nice, France, from September 8 to 10, 2016. The EmboTrap and EmboTrap II revascularization devices are available in Europe to treat patients with acute ischemic stroke. The EmboTrap is currently available for investigational use only in the U.S. under the ARISE II clinical trial, an international clinical trial assessing safety and effectiveness in the United States and Europe. Data from the trial will support a U.S. Food and Drug Administration (FDA) submission for approval to market the device in the United States.

Similar Private Companies By Industry

Company Name Region
Advanced Surgical Concepts Limited Europe
Aegis Surgical Limited Europe
Aerogen Limited Europe
AeroSurgical Ltd. Europe
AltaScience Limited Europe

Recent Private Companies Transactions

Private Placement
November 2, 2016
Private Placement
September 30, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Neuravi Limited, please visit www.neuravi.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.